MHI-TM2000 Linear Accelerator System, Software Version 3.0.0 revision 13 or earlier; Proprietary...
FDA Device Recall #Z-1931-2013 — Class II — June 21, 2013
Recall Summary
| Recall Number | Z-1931-2013 |
| Classification | Class II — Moderate risk |
| Date Initiated | June 21, 2013 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | MITSUBISHI HEAVY INDUSTRIES, LTD., HIROSHIMA MACHINERY WORK |
| Location | HIROSHIMA, N/A |
| Product Type | Devices |
| Quantity | 14 (2 in US) |
Product Description
MHI-TM2000 Linear Accelerator System, Software Version 3.0.0 revision 13 or earlier; Proprietary and Trade Name: MHI-TM2000/ VERO (TM); Common Name: Medical Linear Accelerator. MHI-TM2000 Linear Accelerator System is intended for radiation therapy of lesions, tumors and conditions anywhere in the body where radiation treatment is indicated
Reason for Recall
Software anomaly: Mitsubishi Heavy Industries, Ltd. became aware of a potential safety issue associated with the VERO (TM) Linear Accelerator System. The VERO (TM) may save treatment delivery record into wrong location under certain conditions.
Distribution Pattern
Worldwide distribution: US (nationwide) including states of TX and FL; and countries of: Belgium, Italy, Japan and Korea.
Lot / Code Information
Serial Numbers #s 201902 and 203901
Other Recalls from MITSUBISHI HEAVY INDUSTRIES, LTD., HI...
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-1308-2016 | Class II | VERO MHI-TM2000 Linear Accelerator System --- ... | Mar 7, 2016 |
| Z-1244-2016 | Class II | MHI-TM2000 Linear Accelerator System (Software ... | Dec 15, 2015 |
| Z-1574-2015 | Class II | MHI-TM2000 Linear Accelerator System (Software ... | Apr 17, 2015 |
| Z-0821-2015 | Class II | VERO Linear Accelerator System, Model Number MH... | Dec 2, 2014 |
| Z-2653-2014 | Class II | VERO Linear Accelerator System, Model Number M... | Jul 5, 2014 |
Frequently Asked Questions
A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.